Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0S1GH
|
||||
Former ID |
DNC012808
|
||||
Drug Name |
4-Morpholin-2-yl-benzene-1,2-diol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [526729] | ||
Structure |
Download2D MOL |
||||
Formula |
C10H13NO3
|
||||
Canonical SMILES |
C1COC(CN1)C2=CC(=C(C=C2)O)O
|
||||
InChI |
1S/C10H13NO3/c12-8-2-1-7(5-9(8)13)10-6-11-3-4-14-10/h1-2,5,10-13H,3-4,6H2
|
||||
InChIKey |
GYJRRQRGZZEHEB-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Alpha-1A adrenergic receptor | Target Info | Inhibitor | [526729] | |
Alpha-1B adrenergic receptor | Target Info | Inhibitor | [526729] | ||
Alpha-1D adrenergic receptor | Target Info | Inhibitor | [526729] | ||
NetPath Pathway | IL2 Signaling PathwayNetPath_14:IL2 Signaling Pathway | ||||
Pathway Interaction Database | LPA receptor mediated events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.